ONC considering more options for certification program

The Office of the National Coordinator for Health IT (ONC) is accepting submissions of test procedures, test tools and test data for certification.

The agency published a notice last month in the Federal Register, according to a post on the ONC’s blog authored by CAPT Alicia Morton, DNP, RN-BC, director of the Health IT Certification Program and Tricia Lee Wilkins, PharmD, PhD.

“Improving and streamlining the testing and certification of health IT has long been a goal of ONC,” they wrote. The notice was published in response to healthcare industry stakeholder feedback telling us that certain testing efficiencies could be achieved if the Certification Program were to include the approval of industry-led testing and certification, such as the ePrescribing (eRX) network testing (and certification), they said.

“If approved by the national coordinator, these non-ONC directed tools would qualify as an additional pathway for meeting testing and certification requirements as an alternative to existing testing resources and could provide potential testing and certification efficiency gains. We are excited about the potential of leveraging community supplied tools because there is no limit to the number that can be submitted and we believe that having more testing flexibility will help the program maximize the efficiencies already created and operational-proven by health IT developers.”

Learn more information about ONC’s Certification Program, requirements and testing methods.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.